Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

被引：0
|
作者：
Roisin Adams
Cathal Walsh
Douglas Veale
Barry Bresnihan
Oliver FitzGerald
Michael Barry
机构：
[1] St. James’ Hospital,National Centre for Pharmacoeconomics
[2] Trinity College Dublin,Department of Statistics
[3] Dublin Academic Healthcare,St. Vincent’s University Hospital
来源：
PharmacoEconomics | 2010年 / 28卷
关键词：
Rheumatoid Arthritis; Inflammatory Arthritis; Biological Therapy; Utility Score; Disease Activity Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The growth of economic analyses and in particular cost-utility analyses (CUA), which use the QALY as a measure of outcome, has heightened the interest in the methodologies used to calculate the QALY. The EQ-5D has produced quite different utility values from that of the SF-6D. This article seeks to understand these differences using a cohort of patients with inflammatory arthritis.
引用
收藏
页码：477 / 487
页数：10
相关论文
共 50 条
  • [21] A comparison of the EQ-5D and SF-6D across seven patient groups
    Brazier, J
    Roberts, J
    Tsuchiya, A
    Busschbach, J
    HEALTH ECONOMICS, 2004, 13 (09) : 873 - 884
  • [22] A comparison of the EQ-5D and the SF-6D in patients with pulmonary arterial hypertension
    Brown, MC
    VALUE IN HEALTH, 2005, 8 (06) : A4 - A4
  • [23] Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
    Yousefi, Mahmood
    Najafi, Safa
    Ghaffari, Shahram
    Mahboub-Ahari, Alireza
    Ghaderi, Hossein
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (05)
  • [24] An empirical comparison of EQ-5D and SF-6D in liver transplant patients
    Longworth, L
    Bryan, S
    HEALTH ECONOMICS, 2003, 12 (12) : 1061 - 1067
  • [25] COMPARISON OF SF-6D, EQ-5D AND VAS IN HEMODIALYSIS THAI PATIENT
    Thaweethamcharoen, T.
    Sakulbumrungsil, R.
    Vasuvattakul, S.
    Nopmaneejumruslers, C.
    VALUE IN HEALTH, 2010, 13 (07) : A567 - A567
  • [26] EQ-5D and SF-6D health status measures correlate with disease activity and damage in systemic lupus erythematosus
    Aggarwal, Rohit
    Block, Joel A.
    Jolly, Meenakshi
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4287 - 4287
  • [27] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Kontodimopoulos, Nick
    Argiriou, Michalis
    Theakos, Nikolaos
    Niakas, Dimitris
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (04): : 383 - 391
  • [28] Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis
    Harrison, Mark J.
    Lunt, Mark
    Verstappen, Suzanne M. M.
    Watson, Kath D.
    Bansback, Nick J.
    Symmons, Deborah P. M.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2010, 8
  • [29] DESCRIBING AND COMPARING UTILITY FROM EQ-5D AND SF-6D IN A HUNTINGTON'S DISEASE POPULATION
    Clay, E.
    Perthame, E.
    Maman, K.
    Dorey, J.
    Toumi, M.
    VALUE IN HEALTH, 2011, 14 (07) : A329 - A329
  • [30] Measuring health-related utility: Why the disparity between EQ-5D and SF-6D?
    Bryan S.
    Longworth L.
    The European Journal of Health Economics, 2005, 6 (3) : 253 - 260
12345